392

Bayer Corporation paid 143 million to resolve a whistleblower's allegations that it defrauded the Medicaid and Public Health Service programs by relabeling products sold to a health maintenance organization at deeply discounted rates and then concealing the discounts to avoid paying rebates, in violation of the Medicaid Rebate program. In addition, Bayer paid 108 million to reimburse state Medicaid programs for the same conduct.